|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/341 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| A61K 38/28 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3539540 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19163940.0 |
| Date of filing the European patent application | 2011-11-07 | |
| (97) | Date of publication of the European application | 2019-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-18 |
| (46) | Date of publication of the claims translation | 2025-01-10 |
| (30) | Number | Date | Country code |
| 10190303 | 2010-11-08 | EP | |
| 11151059 | 2011-01-17 | EP |
| (72) |
GREMPLER, Rolf , DE
JOHANSEN, Odd-Erik , DE
KLEIN, Thomas , DE
LUIPPOLD, Gerd , DE
MARK, Michael , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | SGLT2 inhibitorius 1-chlor-4-(beta-D-gliukopiranoz-1-IL)-2-[4-((S)- tetrahidrofuran-3-iloksi)-benzil]-benzenas derinyje su insulinu, skirtas naudoti hipoglikemijos rizikos mažinimui |
| SGLT2 INHIBITOR 1-CHLORO-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3- YLOXY)-BENZYL]-BENZENE IN COMBINATION WITH INSULIN FOR USE IN A METHOD FOR REDUCING THE RISK OF HYPOGLYCEMIA |
| Payment date | Validity (years) | Amount | |
| 2025-10-27 | 15 | 289.00 EUR |
| 2026-11-07 |